ADEL-Y01

· Alzheimer's Disease Expert Lab (ADEL), Inc.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for ADEL-Y01, covering 2026-03-25 to 2026-03-25. Get the full timeline:

Most recent: Clinical Trial Update: A Phase Ia/Ib, First-in-human (FIH) Study for Safety, Tolerability, Pharmacokinetics (PK), and Clinical Activity Evaluation of ADEL-Y01 [Phase 1]

See pricing